Pfizer Inc. Supports ACRP Ride for Diversity in Clinical Research

Pfizer Logo

The Association of Clinical Research Professionals (ACRP) today recognizes Pfizer Inc. as a Breakaway Sponsor of the ACRP Ride for Diversity.

The ACRP Ride for Diversity – a road trip for a reason – is a nonprofit fundraiser supporting ACRP initiatives to develop a diverse and research-ready clinical research workforce.

“Research shows that the more diverse the clinical trial workforce, the more diverse clinical trial participation,” says Susan Landis, ACRP Executive Director. “Clinical studies need to reflect our real-world population—and a more diverse clinical research staff is an important way to make this change happen. We are incredibly thankful for Pfizer’s support.”

“Pfizer is proud to sponsor ACRP’s Ride for Diversity as part of our overall commitment to equity in clinical trials,” said Sandra Amaro, Head of Clinical Trial Diversity at Pfizer. “It’s community efforts like these that will help expand the pool of investigators that conduct research, help raise awareness and improve access to clinical trials for historically underserved communities so all patients can benefit from medical breakthroughs.”

Last year more than 100 sponsors came together to fund the first-ever ACRP Ride for Diversity, a 350-mile bike ride from Pittsburgh to Washington, DC. All donations are allocated for scholarships and programs supporting the growth and development of people of color working in clinical research.

“It is important that ACRP take a stance in today’s society to push organization conducting clinical trials to diversify their workforce because it’s good for science, but more importantly it’s good for mankind,” says Sergio Armani, Vice President, Business Development, North America, Advarra, who is spearheading the ACRP Ride for Diversity with Rick Fisher, Senior Director of Operations, Velocity Clinical Research.

“Diversity in clinical trials is more important than ever as we grow and work together as a society to break down barriers that have held us back for decades,” Fisher adds. “In clinical research, we need to make sure we have greater diversity in the workforce – the clinicians, nurses, and research staff who are face-to-face with potential patients – to fully realize our potential and to safely and ethically deliver new treatments to those in need.”

For more information about the ACRP Ride for Diversity, please visit us online at acrpnet.org/ride.